Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

576 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
BASALIT trial: double-blind placebo-controlled allergen immunotherapy with rBet v 1-FV in birch-related soya allergy.
Treudler R, Franke A, Schmiedeknecht A, Ballmer-Weber B, Worm M, Werfel T, Jappe U, Biedermann T, Schmitt J, Brehler R, Kleinheinz A, Kleine-Tebbe J, Brüning H, Ruëff F, Ring J, Saloga J, Schäkel K, Holzhauser T, Vieths S, Simon JC. Treudler R, et al. Among authors: biedermann t. Allergy. 2017 Aug;72(8):1243-1253. doi: 10.1111/all.13112. Epub 2017 Jan 17. Allergy. 2017. PMID: 27998002 Free article. Clinical Trial.
[Exertion-induced anaphylaxis after eating pork and beef].
Biedermann T, Schöpf P, Ruëff F, Przybilla B. Biedermann T, et al. Dtsch Med Wochenschr. 1999 Apr 16;124(15):456-8. doi: 10.1055/s-2007-1024334. Dtsch Med Wochenschr. 1999. PMID: 10326602 German.
Subcutaneous immunotherapy with a depigmented polymerized birch pollen extract--a new therapeutic option for patients with atopic dermatitis.
Novak N, Thaci D, Hoffmann M, Fölster-Holst R, Biedermann T, Homey B, Schaekel K, Stefan JA, Werfel T, Bieber T, Sager A, Zuberbier T. Novak N, et al. Among authors: biedermann t. Int Arch Allergy Immunol. 2011;155(3):252-6. doi: 10.1159/000320058. Epub 2011 Feb 2. Int Arch Allergy Immunol. 2011. PMID: 21293143 Clinical Trial.
Randomized, double-blind, placebo-controlled study of safety and efficacy of miltefosine in antihistamine-resistant chronic spontaneous urticaria.
Magerl M, Rother M, Bieber T, Biedermann T, Brasch J, Dominicus R, Hunzelmann N, Jakob T, Mahler V, Popp G, Schäkel K, Schlingensiepen R, Schmitt J, Siebenhaar F, Simon JC, Staubach P, Wedi B, Weidner C, Maurer M. Magerl M, et al. Among authors: biedermann t. J Eur Acad Dermatol Venereol. 2013 Mar;27(3):e363-9. doi: 10.1111/j.1468-3083.2012.04689.x. Epub 2012 Aug 29. J Eur Acad Dermatol Venereol. 2013. PMID: 22928719 Clinical Trial.
576 results